Fanconi Anemia Complementation Group E (FANCE), a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular Carcinoma.

Junichi Takahashi,Takaaki Masuda,Akihiro Kitagawa,Taro Tobo,Yusuke Nakano,Tadashi Abe,Yuki Ando,Keisuke Kosai,Yuta Kobayashi,Yoshihiro Matsumoto,Tomoharu Yoshizumi,Masaki Mori,Koshi Mimori

Oncology（2021）

引用 3|浏览11

暂无评分

摘要

FANCE may provide a potential therapeutic target and biomarker of poor prognosis in HCC, possibly by facilitating tumor proliferation, which is mediated partly by cell cycle signaling activation.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要